D. E. Shaw & Co., Inc. Ionis Pharmaceuticals Inc Call Options Transaction History

D. E. Shaw & Co., Inc.

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q2 2019 Aug 14, 2019	BUY	$62.09 - $86.14 $552,601 - $766,646	8,900 Added 29.67%	38,900 $2.5 Million
Q1 2019 May 15, 2019	BUY	$52.92 - $81.17 $1.59 Million - $2.44 Million	30,000 New	30,000 $2.44 Million

505

154M

2.69M

1.03M

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $10.2B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.